Würzburg
Uniklinikum Würzburg
Pharmaceutical Screening in vestibular schwannoma ex vivo tumor slice model
Change of white matter integrity of the Corpus Callosum after surgery in patients with high grade gliomas
Establishment of a novel ex vivo model for the assessment of Tumor Treating Fields (TTFields) effects on the blood-brain barrier (BBB)
CAR-T cells against three novel antigens show antitumoral efficacy in ex vivo patient derived glioblastoma organoids
Decompressive craniectomy in patients with aneurysmal subarachnoid hemorrhage – Futile attempt or live saver?
Interdisciplinary treatment & teaching concept in a series of 1,036 vestibular schwannomas
A combination of CAR-T cell specificities can overcome antigen escape mechanisms in ex vivo glioblastoma models
Tumormicroenvironment in Vestibular schwannoma with and without NF2
Metastasis associated in colorectal cancer 1 (MACC1) mRNA expression in vestibular schwannoma
Intraoperative MRI-guided resection compared to 5-ALA-guidance in newly diagnosed glioblastoma: A prospective controlled multicenter clinical trial
Introducing an innovative and time-effective method to generate ex vivo patient-derived glioblastoma organoid models
Co-culture of PBMCs and patient derived organoids enhances glioblastoma tumor microenvironment
Facial nerve outcome in vestibular schwannomas – which concept holds true at long-term?
Ex vivo glioblastoma organoids reflect tumor microenvironment
Effects of Tumor Treating Fields (TTFields) on glioblastoma, anaplastic ependymoma and oligodendroglioma samples in a patient-derived ex vivo organoid model
Management of Vestibular Schwannoma: Impact of cranial nerve deficits on the QoL
Importance of extent of resection for survival in patients with newly diagnosed glioblastoma: Results from a prospective controlled multicenter study
Multi-modality monitoring of auditory function in cerebellopontine angle surgery
Management of Vestibular Schwannoma: The impact of an intermediate nerve disturbance
Serum concentration guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: Retrospective evaluation of a 12-year single center experience
We use cookies on our website. Cookies are small (text) files that are created and stored on your device (e.g., smartphone, notebook, tablet, PC). Some of these cookies are technically necessary to operate the website, other cookies are used to extend the functionality of the website or for marketing purposes. Apart from the technically necessary cookies, you are free to allow or not allow cookies when visiting our website.